
SOLVE FSHD Advances Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD
SOLVE FSHD Accelerates Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD SOLVE FSHD announced new nonclinical data supporting SFH-4090 for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The data were presented at the 31st Annual Congress of the World…













